Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Lidocaine for Pediatric Migraine
NCT03806595Phase 1Completed
- Sponsor
- University of British Columbia
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of lidocaine 10% oropharyngeal spray in migraine and post-traumatic headache (PTH) (2 arms), sponsored by University of British Columbia. Primary endpoint: Change in migraine pain at 60 months. Started Jul 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
migrainepost-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT03806595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03806595.